ATE441102T1 - Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen - Google Patents

Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen

Info

Publication number
ATE441102T1
ATE441102T1 AT05718286T AT05718286T ATE441102T1 AT E441102 T1 ATE441102 T1 AT E441102T1 AT 05718286 T AT05718286 T AT 05718286T AT 05718286 T AT05718286 T AT 05718286T AT E441102 T1 ATE441102 T1 AT E441102T1
Authority
AT
Austria
Prior art keywords
parameters
change
luminescent protein
protein probe
detecting intracellular
Prior art date
Application number
AT05718286T
Other languages
English (en)
Inventor
Rosario Rizzuto
Tullio Pozzan
Paolo Pinton
Carlotta Giorgi
Original Assignee
Aequotech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aequotech S R L filed Critical Aequotech S R L
Application granted granted Critical
Publication of ATE441102T1 publication Critical patent/ATE441102T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05718286T 2004-03-26 2005-03-23 Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen ATE441102T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000598A ITMI20040598A1 (it) 2004-03-26 2004-03-26 Metodo per la rilevazione di parametri intracellulari con sonde proteiche luminescenti per lo screening di molecole in grado di alterare detti parametri
PCT/IB2005/000795 WO2005093429A2 (en) 2004-03-26 2005-03-23 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters

Publications (1)

Publication Number Publication Date
ATE441102T1 true ATE441102T1 (de) 2009-09-15

Family

ID=35033456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05718286T ATE441102T1 (de) 2004-03-26 2005-03-23 Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen

Country Status (7)

Country Link
US (1) US20080003569A1 (de)
EP (1) EP1730499B1 (de)
JP (1) JP2007530027A (de)
AT (1) ATE441102T1 (de)
DE (1) DE602005016230D1 (de)
IT (1) ITMI20040598A1 (de)
WO (1) WO2005093429A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10052497B2 (en) 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
EP1919497B1 (de) 2005-07-22 2020-02-12 The Board of Trustees of the Leland Stanford Junior University Lichtaktivierter kationenkanal und dessen verwendung
WO2008086470A1 (en) 2007-01-10 2008-07-17 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
WO2008106694A2 (en) 2007-03-01 2008-09-04 The Board Of Trustees Of The Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
JP5801188B2 (ja) 2008-04-23 2015-10-28 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞を光刺激するためのシステム、方法、および組成物
MY152003A (en) * 2008-05-29 2014-08-15 Univ Leland Stanford Junior Cell line, system and method for optical control of secondary messengers
MY162929A (en) 2008-06-17 2017-07-31 Univ Leland Stanford Junior Apparatus and methods for controlling cellular development
US9101759B2 (en) 2008-07-08 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
WO2012061679A2 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
EP2635111B1 (de) 2010-11-05 2018-05-23 The Board of Trustees of the Leland Stanford Junior University Stabilisierte opsin-proteine mit stufenfunktion und verwendungsverfahren dafür
CA2816972C (en) 2010-11-05 2019-12-03 The Board Of Trustees Of The Leland Stanford Junior University Control and characterization of memory function
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
CA2816968C (en) 2010-11-05 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Optically-controlled cns dysfunction
WO2012061688A1 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of reward-related behaviors
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
ES2724803T3 (es) 2011-12-16 2019-09-16 Univ Leland Stanford Junior Polipéptidos opsinas y métodos de utilización de los mismos
CN104363961B (zh) 2012-02-21 2017-10-03 斯坦福大学托管董事会 用于治疗盆底神经源性病症的组合物和方法
JP6594854B2 (ja) 2013-03-15 2019-10-23 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 行動状態の光遺伝学的制御方法
JP6549559B2 (ja) 2013-04-29 2019-07-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞における活動電位の光遺伝学的調節のための装置、システム及び方法
JP6621747B2 (ja) 2013-08-14 2019-12-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 疼痛を制御するための組成物及び方法
WO2016209654A1 (en) 2015-06-22 2016-12-29 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958713A (en) * 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
ATE232298T1 (de) * 1998-07-06 2003-02-15 Euroscreen Sa Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors
WO2003082904A2 (en) * 2002-03-25 2003-10-09 Chemicon International Inc. Modified aequorins having enhanced glowing kinetics and methods of using same

Also Published As

Publication number Publication date
EP1730499A2 (de) 2006-12-13
WO2005093429A3 (en) 2006-04-13
US20080003569A1 (en) 2008-01-03
WO2005093429A2 (en) 2005-10-06
DE602005016230D1 (de) 2009-10-08
EP1730499B1 (de) 2009-08-26
ITMI20040598A1 (it) 2004-06-26
JP2007530027A (ja) 2007-11-01

Similar Documents

Publication Publication Date Title
ATE441102T1 (de) Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen
EP3953374A4 (de) Zusammensetzungen und verfahren zur detektion von analyten mittels biolumineszenz
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
ATE514090T1 (de) Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen
EA201500316A1 (ru) Антагонисты толл-подобного рецептора 3
PL2021794T3 (pl) Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy
WO2009113814A3 (ko) 간암 진단용 단백질성 마커
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE454632T1 (de) Verfahren zur beurteilung der lebensfähigkeit von embryos
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
ATE517345T1 (de) Verfahren zur analyse von proben mit einem mittel zur gasentwicklung
DE502006001103D1 (de) Verfahren zur Klassifizierung von ditgital modulierten Signalen
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
EP1883252A4 (de) Vorrichtung zur detektion von anomalien
EP1883251A4 (de) Vorrichtung zur detektion von anomalien
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE533055T1 (de) Verfahren zum screenen mithilfe von konformationsempfindlichen peptiden
ATE443871T1 (de) Test zum nachweis von pathologischen prionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties